Compound index — C
1,779 substances begin with C. 10 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 200 of them, Camizestrant – Carnosine.
US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
cAMP CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003217
Campath-1 Antigen US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003218
Camphechlor US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003219
Camphor CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: bulk ingredient
Class as recordedActively Acquired Immunity [PE]; Adenovirus [Chemical/Ingredient]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]
Market presence692 US product listings · 159 Canadian licensed products
Etalyn identifierETA-C-003220
Camphor Oil US-DRUG Not yet graded
US: otc monograph drug
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003222
Camphor, (-)- US-DRUG Not yet graded
US: otc monograph drug
Market presence32 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003221
Camphora CA-NHP Not yet graded
CA licensed ingredient
Market presence41 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003223
Camphora camphora (L.) Karst. CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003224
Camphora monobromata CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003225
Camphora naturalis CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003226
Camphoric Acid US-DRUG Not yet graded
US: otc monograph drug
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003227
Camphoric Acid, (+)- US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003228
Camphoricum acidum CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003229
Camponotus Pennsylvanicus US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Ant Venoms [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003230
Campsis grandiflora CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003231
Campsis Radicans Flower US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fungal Proteins [CS]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003232
Campylobacter Jejuni US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedActively Acquired Immunity [PE]; Adenovirus [Chemical/Ingredient]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003233
Campylotropis trigonoclada CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003234
Camu Camu Fruit CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003235
Canagliflozin EU-MEDUS-DRUG Not yet graded
Canakinumab EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fruit Proteins [EXT]
Earliest US approval2009
Market presence8 US product listings · 1 FDA applications · 2 EU medicines
Etalyn identifierETA-C-003237
Cananga odorata CA-NHP Not yet graded
CA licensed ingredient
Market presence99 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003238
Cananga Odorata Leaf Oil US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003239
Canarium album CA-NHP Not yet graded
CA licensed ingredient
Market presence20 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003240
Canarium Album Root US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003241
Canarium Album Whole US-DRUG Not yet graded
US: otc monograph drug
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003242
Canarium indicum L. EU-NOVEL Not yet graded
Authorised novel food
Parts in scopeDried nuts
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-003243
Canarium ovatum Engl. EU-NOVEL Not yet graded
Authorised novel food
Parts in scopeDried nuts
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-003244
Canarypox virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-003245
canarypox virus expressing feline leukemia virus EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedQI06AH
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-003246
Canavalia gladiata CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003247
Candesartan Cilexetil US-DRUG Not yet graded
US: anda
Class as recordedAngiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]
Earliest US approval1998
Market presence65 US product listings · 16 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003248
Candicidin US-DRUG Not yet graded
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003249
Candida Albicans CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: bla
Class as recordedAcidifying Activity [MoA]; Actively Acquired Immunity [PE]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]
Market presence201 US product listings · 71 Canadian licensed products
Etalyn identifierETA-C-003250
Candida Albicans DNA US-DRUG Not yet graded
US: drug for further processing
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Increased Histamine Release [PE]
Market presence22 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003251
Candida Parapsilosis CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: drug for further processing
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Antigens
Market presence43 US product listings · 15 Canadian licensed products
Etalyn identifierETA-C-003252
Candida Parapsilosis DNA US-DRUG Not yet graded
US: drug for further processing
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Increased Histamine Release [PE]
Market presence12 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003253
Candida rugosa CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003254
Candida Torresii US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003255
Candida Tropicalis US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fungal Proteins [CS]
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003256
Cangrelor EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedB01; Decreased Platelet Aggregation [PE]; P2Y12 Platelet Inhibitor [EPC]; P2Y12 Receptor Antagonists [MoA]
Earliest US approval2015
Market presence5 US product listings · 3 FDA applications · 1 EU medicines
Etalyn identifierETA-C-003257
Cangrelor Tetrasodium US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003258
canine adenovirus type 2 EU-MED Not yet graded
EU medicine: Authorised
Market presence3 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-003259
canine distemper virus EU-MED Not yet graded
EU medicine: Authorised
Market presence3 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-003260
Canine herpesvirus (F205 strain) antigens EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-003261
Canine Morbillivirus US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003262
canine parainfluenza type 2 virus EU-MED Not yet graded
EU medicine: Authorised
Market presence3 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-003263
canine parainfluenza type-2 virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-003264
canine parainfluenza virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-003265
canine parvovirus type 2b EU-MED Not yet graded
EU medicine: Authorised
Market presence3 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-003266
Canis Lupus Familiaris Dander US-DRUG Not yet graded
US: bla
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence9 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003267
Canis Lupus Familiaris Hair US-DRUG Not yet graded
US: bla
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Animal Fur [CS]
Market presence22 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003268
Canis Lupus Familiaris Milk US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]
Market presence53 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003269
Canis Lupus Familiaris Skin US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Animal Fur [CS]; Antigens; Bee Venoms [CS]
Market presence16 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003270
Cannabidiol EU-MEDEU-NOVELUS-DRUG Not yet graded
EU medicine: AuthorisedNovel, not yet authorisedUS: bulk ingredient
Class as recordedCannabinoids [CS]; Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2B6 Inhibitors [MoA]
Earliest US approval2018
Market presence9 US product listings · 1 FDA applications · 1 EU medicines
Parts in scopeWhole
Etalyn identifierETA-C-003271
Cannabimimetic agents US-CSA Not yet graded
CSA Schedule I
Class as recordedDEA: hallucinogen / synthetic cannabinoid
DEA other namesAny substance meeting the definition of; cannabimimetic agent as set forth in 21 CFR §; 1308.11(g)
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-003272
Cannabinoids EU-NOVEL Not yet graded
Novel, not yet authorised
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-003273
Cannabis flos EU-HERB Not yet graded
Herbal monograph: D: Draft under discussion
also: Cannabis sativaL.; Cannabis flowering tops
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-003274
Cannabis sativa CA-NHP Not yet graded
CA licensed ingredient
Market presence760 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003275
Cannabis sativa L. EU-NOVEL Not yet graded
Not novel in food
Parts in scopeSeeds; Water infusion of hemp leaves (when not accompanied by the flowering and
fruiting tops) consumed as such or as part of herbal infusions; Soluble edestin from Cannabis sativa L.
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-003276
Cannabis Sativa seed CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003277
Cannabis Sativa Seed Oil US-DRUG Not yet graded
US: otc monograph drug
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003278
Cannabis Sativa Subsp. Sativa Flowering TOP US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedCentral Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; Methylxanthine [EPC]; Xanthines [CS]
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003279
Canola Oil CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Corticosteroid Hormone Receptor Agonists [MoA]
Market presence3 US product listings · 11 Canadian licensed products
Etalyn identifierETA-C-003280
Canola protein isolate CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003281
Canrenone US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003282
Canscora decussata CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003283
Cantaloupe US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fruit Proteins [EXT]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003284
Cantharidin US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval2023
Market presence10 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003285
Cantharis CA-NHP Not yet graded
CA licensed ingredient
Market presence63 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003286
Cantharis vesicatoria CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003287
Capecitabine EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: anda
Class as recordedL01BC06; Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]
Earliest US approval1998
Market presence54 US product listings · 15 FDA applications · 6 EU medicines
Etalyn identifierETA-C-003288
Caplacizumab-Yhdp US-DRUG Not yet graded
Earliest US approval2019
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003291
capmatinib dihydrochloride monohydrate EU-MED Not yet graded
EU medicine: Authorised
Class as recordedL01EX17
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-003293
Capmatinib Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 1A2 Inhibitors [MoA]; Kinase Inhibitor [EPC]; Mesenchymal Epithelial Transition Inhibitors [MoA]
Earliest US approval2020
Market presence6 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003292
Capra hircus CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003295
Capra Hircus Hair US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Animal Fur [CS]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003296
Capra Hircus Skin US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Animal Fur [CS]; Antigens; Cell-mediated Immunity [PE]
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003297
Capreomycin Sulfate US-DRUG Not yet graded
Earliest US approval1971
Market presence3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003298
Capric Acid US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Catecholamine [EPC]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003299
Capromab Pendetide US-DRUG Not yet graded
Earliest US approval1996
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003300
Caprylic Acid CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence1 US product listings · 1 Canadian licensed products
Etalyn identifierETA-C-003302
Caprylic/capric Triglyceride US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Glycerol [CS]; Increased Histamine Release [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003303
Capryloyl Glycine US-DRUG Not yet graded
US: unapproved drug other
Class as recordedDecreased Protein Synthesis [PE]; Decreased Sebaceous Gland Activity [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003304
Caprylyl Glycol US-DRUG Not yet graded
US: otc monograph final
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Glycerol [CS]; Increased Histamine Release [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003305
Capsaicin CA-NHPEU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedCA licensed ingredientUS: bulk ingredient
Class as recordedAmide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]; Local Anesthesia [PE]
Earliest US approval2009
Market presence204 US product listings · 1 FDA applications · 1 EU medicines · 11 Canadian licensed products
Etalyn identifierETA-C-003306
Capsella Bursa-Pastoris CA-NHPUS-DRUG Not yet graded
Capsella Bursa-Pastoris TOP US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Ammonium Ion Binding Activity [MoA]; Bee Venoms [CS]; Cell-mediated Immunity [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003308
Capsella Bursa-Pastoris Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Ammonium Ion Binding Activity [MoA]; Bee Venoms [CS]; Blood Coagulation Factor [EPC]
Market presence9 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003309
Capsici fructus CA-NHPEU-HERBUS-DRUG Not yet graded
Herbal monograph: F: Assessment finalisedCA licensed ingredientUS: drug for further processing
also: Capsicum; Capsicum annuum L. var. minimum (Miller) Heiser
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]
Market presence164 US product listings · 7 Canadian licensed products
Etalyn identifierETA-C-003310
Capsicum annuum CA-NHP Not yet graded
CA licensed ingredient
Market presence1,259 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003311
Capsicum annuum var. annuum CA-NHP Not yet graded
CA licensed ingredient
Market presence20 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003312
Capsicum Annuum Whole US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003313
Capsicum chinense CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003314
Capsicum grossum CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003316
Capsicum Oleoresin US-DRUG Not yet graded
US: otc monograph drug
Market presence13 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003317
capsid protein antigen EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-003318
Captopril US-DRUG Not yet graded
US: anda
Class as recordedAngiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]
Earliest US approval1981
Market presence55 US product listings · 33 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003319
Carapichea ipecacuanha CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003321
Carapichea Ipecacuanha Whole US-DRUG Not yet graded
US: drug for further processing
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003322
Caraway Seed US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence10 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003323
Carbachol US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAdrenergic alpha-Agonists [MoA]; Cholinergic Agonists [MoA]; Cholinergic Receptor Agonist [EPC]; alpha-Adrenergic Agonist [EPC]
Earliest US approval1972
Market presence3 US product listings · 4 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003324
Carbamazepine US-DRUG Not yet graded
US: anda
Class as recordedCytochrome P450 1A2 Inducers [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C9 Inducers [MoA]
Earliest US approval1968
Market presence174 US product listings · 52 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003325
Carbamide CA-NHP Not yet graded
CA licensed ingredient
Market presence79 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003326
Carbenicillin Disodium US-DRUG Not yet graded
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003328
Carbenicillin Indanyl Sodium US-DRUG Not yet graded
Earliest US approval1972
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003329
Carbidopa EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: anda
Class as recordedAmino Acids; Aromatic Amino Acid [EPC]; Aromatic [CS]; Catechol O-Methyltransferase Inhibitors [MoA]
Earliest US approval1975
Market presence182 US product listings · 56 FDA applications · 5 EU medicines
Etalyn identifierETA-C-003330
Carbidopa,levodopa US-DRUG Not yet graded
Earliest US approval2025
Market presence3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003331
Carbimazole US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003332
Carbinoxamine Maleate US-DRUG Not yet graded
US: anda
Class as recordedHistamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
Earliest US approval2003
Market presence15 US product listings · 13 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003333
Carbo Animalis CA-NHPUS-DRUG Not yet graded
Carbo mineralis CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003335
Carbo vegetabilis CA-NHP Not yet graded
CA licensed ingredient
Market presence143 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003336
Carbocysteine US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003337
Carbohydrate EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Provides energy. Re-energises during and post exercise bouts” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-003338
Carbohydrate and protein combination EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Optimizes muscle glycogen and protein synthesis and muscle recovery. Helps to rebuild muscles after exercise (scientifically proven). Prepares for the next workout faster Jumpstart muscle recover. Helps muscles recover their energy - rebuild muscle glycogen, repair muscle protein” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-003339
Carbohydrate electrolyte drinks EU-CLAIM Not yet graded
EU claims 0 authorised / 3 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Before and during exercise increase endurance capacity / time to exhaustion / delays fatigue. Provide carbohydrate to muscles to supplement glycogen stores. Ingestion before and during exercise maintains blood glucose. Maintain skills during prolonged exercise Can help improve sprint / jump performance Gives athletes a performance edge During exercise maintains endurance performance / perform for longer. Provides…” | Non-authorised | Art.13(1) | EFSA opinion |
| “Consumption before and during exercise enhances feelings of energetic arousal which may impact on task persistence and performance Helps reduce the perception of effort, making you feel better during exercise Reduces the perception of athletic fatigue. Helps maintain alertness during later stages of exercise Helps improve readiness/ motivation Helps enhance feelings of pleasure” | Non-authorised | Art.13(1) | EFSA opinion |
| “help delay the onset of fatigue during a subsequent bout of exercise helps you to perform for longer improves subsequent endurance capacity can help the body recover more effectively from exercise ensures adequate hydration and restores endurance capacity liquid carbohydrate is as effective, if not more effective than a solid form for glycogen resynthesis” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-003340
Carbohydrate foods and beverages EU-CLAIM Not yet graded
EU claims 0 authorised / 6 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “/ maximises glycogen stores. Carbohydrate before, during exercise improves endurance performance / perform for longer. Carbohydrate rich diets before exercise help elevate pre-exercise glycogen stores. Ingestion during exercise maintains blood glucose. Glucose is the body's naturally preferred source of energy during intense exercise Consumption in events as short as 1 hr improves exercise performance. Endurance…” | Non-authorised | Art.13(1) | EFSA opinion |
| “Carbohydrate after exercise maximises muscle glycogen replacement. High GI carbohydrate post exercise results in higher muscle glycogen levels after 24 hours than low GI. Liquid carbohydrate is as effective as a solid form for glycogen resynthesis. Replaces glycogen stores used during exercise. Consumption at frequent intervals maintains enhanced muscle glycogen synthesis. Helps recovery and enhances subsequent…” | Non-authorised | Art.13(1) | EFSA opinion |
| “Carbohydrate after exercise maximises muscle glycogen replacement. High GI carbohydrate post exercise results in higher muscle glycogen levels after 24 hours than low GI. Liquid carbohydrate is as effective as a solid form for glycogen resynthesis. Replaces glycogen stores used during exercise. Consumption at frequent intervals maintains enhanced muscle glycogen synthesis. Helps recovery and enhances subsequent…” | Non-authorised | Art.13(1) | EFSA opinion |
| “Consumption before and during exercise enhances feelings of energetic arousal which may impact on task persistence and performance Reduces the perception of athletic fatigue Helps maintain alertness / mood Helps reduce the perception of effort, making you feel better during exercise A high carbohydrate diet helps to reduce feelings of fatigue / perceived effort during prolonged exercise” | Non-authorised | Art.13(1) | EFSA opinion |
| “Consumption before and during exercise enhances feelings of energetic arousal which may impact on task persistence and performance. Reduces the perception of athletic fatigue. Helps maintain alertness / mood. Helps reduce the perception of effort, making you feel better during exercise. A high carbohydrate diet helps to reduce feelings of fatigue / perceived effort during prolonged exercise.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Enhances / maximises glycogen stores. Carbohydrate before, during exercise improves endurance performance / perform for longer. Carbohydrate rich diets before exercise help elevate pre-exercise glycogen stores. Ingestion during exercise maintains blood glucose. Glucose is the body's naturally preferred source of energy during intense exercise. Consumption in events as short as 1 hr improves exercise performance…” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-003341
Carbohydrate solutions EU-CLAIM Not yet graded
EU claims 1 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Carbohydrate solutions contribute to the improvement of physical performance during a high-intensity and long-lasting physical exercise in trained adults.” | Authorised | Art.13(5) | EFSA opinion |
| “Carbohydrate solutions contribute to the maintenance of endurance performance during prolonged endurance exercice.” | Non-authorised | Art.13(5) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-003343
Carbohydrate sources with low glycaemic index (GI <55), e.g. legumes, vegetables, whole grain cereals EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Consumption of low GI (low glycaemic index) foods with in the healthy diet (low glycaemic load - GL) can contribute to the maintenance of the normal blood sugar level, blood lipid level (triglyceride) and body mass.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-003344
Carbohydrate, protein and lipid combination EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Helps your body rapidly rebuild so that you can perform at your peak during your next workout. Rebuild muscle glycogen. Repair muscle protein. Restore muscle lipid.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-003342
Carbohydrate-electrolyte solutions EU-CLAIM Not yet graded
EU claims 2 authorised / 0 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Carbohydrate-electrolyte solutions contribute to the maintenance of endurance performance during prolonged endurance exercise” | Authorised | Art.13(1) | EFSA opinion |
| “Carbohydrate-electrolyte solutions enhance the absorption of water during physical exercise” | Authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-003345
Carbohydrates EU-CLAIM Not yet graded
EU claims 2 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Carbohydrate-containing foods have a beneficial impact on exercise performance. Carbohydrate is a key energy source prior to exercise.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Carbohydrate-containing foods help to rebuild liver and muscle glycogen stores after exercise.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Carbohydrates contribute to the maintenance of normal brain function” | Authorised | Art.13(1) | EFSA opinion |
| “Carbohydrates contribute to the recovery of normal muscle function (contraction) after highly intensive and/or long-lasting physical exercise leading to muscle fatigue and the depletion of glycogen stores in skeletal muscle” | Authorised | Art.13(5) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-003346
Carbohydrates in dairy products EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Carbohydrates in dairy products have very low glycemic index (GI); Carbohydrates in dairy products give a very low and slow blood glucose response.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-003347
Carbohydrates in pasta products EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Kolhydrater i pasta ger ett lågt och långsamt blodsockersvar/har ett lågt glykemiskt index (GI). Carbohydrates in pasta products provide a low and slow blood sugar response/have a low glycaemic index (GI).” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-003348
Carbohydrates that induce a low glycaemic response EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Low glycaemic carbohydrates / low glycaemic [carbohydrate] diet helps maintain and improve blood glucose control; Low glycaemic carbohydrates / low glycaemic [carbohydrate] diet helps in the management of regular blood glucose levels; Low glycaemic carbohydrates / low glycaemic [carbohydrate] diet supports body weight regulation; Low glycaemic carbohydrates / low glycaemic[carbohydrate] diet contributes to weight…” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-003349
Carbohydrates that induce a reduced glycaemic response EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Due to its (modified) carbohydrate composition, this food has a lower blood glucose and insulin response; This food has a [x%] lower impact on blood sugar levels than comparable foods and thus helps to maintain more steady blood sugar levels;” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-003350
Carbohydrates with a low glycaemic index (GI) EU-CLAIM Not yet graded
EU claims 0 authorised / 3 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “-a low GI [carbohydrate] diet helps to maintain healthy cholesterol levels.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Low GI carbohydrates sustain steady blood sugar levels.” | Non-authorised | Art.13(1) | EFSA opinion |
| “low GI [carbohydrate] foods help you feel fuller for longer” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-003351
Carbohydrates with a low glycaemic load EU-CLAIM Not yet graded
EU claims 0 authorised / 4 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “A low GL diet helps to maintain a healthy weight” | Non-authorised | Art.13(1) | EFSA opinion |
| “A low GL diet helps to maintain healthy cholesterol levels” | Non-authorised | Art.13(1) | EFSA opinion |
| “A low GL diet sustains steady blood sugar levels” | Non-authorised | Art.13(1) | EFSA opinion |
| “Low GL foods help keep you fuller for longer” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-003352
Carbohydrates with a low glycaemic response EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “low glycemic carbohydrates / low glycemic [carbohydrate] diet helps maintain and improve blood glucose control; -low glycemic carbohydrates / low glycemic [carbohydrate] diet helps in the management of regular blood glucose levels;” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-003353
Carbohydrates with a reduced glycemic response EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “due to its (modified) carbohydrate composition, this food has a lower blood glucose and insulin response; -this food has a [x%] lower impact on blood sugar levels than comparable foods and thus helps to maintain more steady blood sugar levels” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-003354
Carbolicum acidum CA-NHP Not yet graded
CA licensed ingredient
Market presence16 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003355
Carbomer Copolymer Type A (allyl Pentaerythritol Crosslinked) US-DRUG Not yet graded
US: otc monograph final
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Anti-coagulant [EPC]; Ascorbic Acid [CS]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003356
Carbomer Homopolymer, Unspecified Type US-DRUG Not yet graded
US: otc monograph final
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Anti-coagulant [EPC]; Ascorbic Acid [CS]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003357
Carbon Dioide US-DRUG Not yet graded
Earliest US approval2020
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003358
Carbon Dioxide US-DRUG Not yet graded
US: drug for further processing
also: Carbon Dioxide, USP
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]
Earliest US approval2013
Market presence67 US product listings · 18 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003359
Carbon Disulfide US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence32 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003360
Carbon Monoxide US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003361
Carbon Tetrachloride US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Antiseptic [EPC]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003362
Carbonate ION US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003364
Carbonate/Bicarbonate as salts of Ca, Mg, Na, K EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Bicarbonates/Carbonates help maintain acid -base balance; Bicarbonates/Carbonates help maintain strong bones” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-003363
Carboneum CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003365
Carboneum chloratum CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003366
Carboneum hydrogenisatum CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003367
Carboneum oxygenisatum CA-NHP Not yet graded
CA licensed ingredient
Market presence7 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003368
Carboneum sulphuratum CA-NHP Not yet graded
CA licensed ingredient
Market presence16 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003369
Carboneum tetramuriaticum CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003370
Carbonic acid calcium salt CA-NHP Not yet graded
CA licensed ingredient
Market presence125 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003371
Carbonic acid potassium salt (1:1) CA-NHP Not yet graded
CA licensed ingredient
Market presence13 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003374
Carbonic acid sodium salt (1:1) CA-NHP Not yet graded
CA licensed ingredient
Market presence114 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003375
Carbonic acid, diammonium salt CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003372
Carbonic acid, magnesium salt (1:1) CA-NHP Not yet graded
CA licensed ingredient
Market presence20 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003373
Carbonic acid, zinc salt (1:1) CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003376
Carbonyldiamide CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003377
Carboplatin US-DRUG Not yet graded
US: anda
Class as recordedPlatinum-based Drug [EPC]; Platinum-containing Compounds [EXT]
Earliest US approval1989
Market presence48 US product listings · 37 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003378
Carboprost Tromethamine US-DRUG Not yet graded
US: anda
Class as recordedProstaglandin Analog [EPC]; Prostaglandins [CS]
Earliest US approval1979
Market presence28 US product listings · 14 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003379
(Carboxymethyl)trimethylammonium hydroxide inner salt CA-NHP Not yet graded
CA licensed ingredient
Market presence413 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014870
Carboxymethylcellulose US-DRUG Not yet graded
US: drug for further processing
also: Carboxymethylcellulose Sodium, Unspecified
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Glycerol [CS]
Market presence87 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003380
Carboxymethylcellulose Sodium, Unspecified Form US-DRUG Not yet graded
US: otc monograph drug
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence14 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003381
Carcinosin CA-NHP Not yet graded
CA licensed ingredient
Market presence20 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003382
Carcinosin adeno stomach CA-NHP Not yet graded
CA licensed ingredient
Market presence7 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003383
Carcinosin adeno vesica CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003384
Carcinosin intestinal comp. CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003385
Carcinosin scirrhus mammae CA-NHP Not yet graded
CA licensed ingredient
Market presence7 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003386
Cardamom US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003387
Cardarine ETALYN E/insufficientband 6
also: GW1516; GW501516; endurobol
Recorded from — 0 of 7 registers
Etalyn identifierETA-C-003388
Cardiospermum CA-NHP Not yet graded
CA licensed ingredient
Market presence7 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003389
Cardiospermum Grandiflorum Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003390
Cardiospermum halicacabum CA-NHP Not yet graded
CA licensed ingredient
Market presence17 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003391
Cardiospermum Halicacabum Flowering TOP US-DRUG Not yet graded
US: drug for further processing
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003392
Carduus marianus CA-NHP Not yet graded
CA licensed ingredient
Market presence104 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003394
Carduus marianus-ethanol decoctum CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003395
Carfentanil US-CSA Not yet graded
CSA Schedule IInarcotic
Class as recordedDEA: narcotic / opioid
DEA other namesWildnil
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-003396
Carfilzomib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedL01XX45; Proteasome Inhibitor [EPC]; Proteasome Inhibitors [MoA]
Earliest US approval2012
Market presence17 US product listings · 10 FDA applications · 1 EU medicines
Etalyn identifierETA-C-003397
Carglumic Acid EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedA16AA05; Carbamoyl Phosphate Synthetase 1 Activator [EPC]; Carbamoyl Phosphate Synthetase 1 Activators [MoA]
Earliest US approval2010
Market presence10 US product listings · 3 FDA applications · 2 EU medicines
Etalyn identifierETA-C-003398
Carica papaya CA-NHPEU-CLAIMEU-NOVEL Not yet graded
Under consultationEU claims 0 authorised / 1 refusedCA licensed ingredient
Market presence420 Canadian licensed products
Parts in scopeFruit oil; Seeds and leaves; Fruit
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Contains antioxidant/s; Is a source of antioxdiant/s. With antioxidant/s. Antioxidant activity '-Contributes to the protection against oxidation; - contributes to the protection against free radicals” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-003399
Carica Papaya Whole US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003400
Carica pentagona EU-NOVEL Not yet graded
Not novel in food
also: Vasconcellea pentagona (Heilborn) Mabb.
Parts in scopeFruit
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-003401
Cariprazine EU-MEDUS-DRUG Not yet graded
carisbamate EU-MED Not yet graded
EU medicine: Application withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-003403
Carisoprodol US-CSAUS-DRUG Not yet graded
CSA Schedule IVUS: anda
Class as recordedCentrally-mediated Muscle Relaxation [PE]; DEA: precursor / immediate precursor; Muscle Relaxant [EPC]
Earliest US approval1959
Market presence68 US product listings · 36 FDA applications
DEA other namesSoma
Etalyn identifierETA-C-003404
Carissa carandus EU-NOVEL Not yet graded
Not novel in supplements
Parts in scopeLeaves, fruits, roots, bark and wood
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-003405
Carlina acaulis CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003406
Carlina Vulgaris Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003407
Carlsbad aqua CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-003408
Carmustine EU-MEDUS-DRUG Not yet graded
Carnegiea Gigantea Flower US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-003410
Carnitine CA-NHPEU-CLAIMUS-DRUG Not yet graded
EU claims 0 authorised / 12 refusedCA licensed ingredientUS: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]
Market presence2 US product listings · 1,276 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Helps improve muscle recovery after exercise -helps maintain optimal repair of muscle tissue -supports athletes in recovery from weight training -can help recreationally weight-trained in recovery from exercise -contributes to the reduction of muscle soreness from exercise in trained athletes” | Non-authorised | Art.13(1) | EFSA opinion |
| “Helps the energy production in the cell by transporting fatty acids in places where they are used and metabolised -contributes to the fat burning during exercise -contributes to increased fat oxidation -is important for the oxidation of fat -helps improve muscle recovery after exercise -helps maintain optimal repair of muscle tissue -plays an important role in lipid metabolism -can support lipid metabolism converts…” | Non-authorised | Art.13(1) | EFSA opinion |
| “Helps the energy production in the cell by transporting fatty acids in places where they are used and metabolised -contributes to the fat burning during exercise -contributes to increased fat oxidation -is important for the oxidation of fat -helps improve muscle recovery after exercise -helps maintain optimal repair of muscle tissue -plays an important role in lipid metabolism -can support lipid metabolism converts…” | Non-authorised | Art.13(1) | EFSA opinion |
| “Helps to maintain healthy blood cholesterol and plasma lipid levels in the elderly.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Helps the energy production in the cell by transporting fatty acids in places where they are used and metabolised/contributes to the fat burning during exercise/contributes to increased fat oxidation/is important for the oxidation of fat/helps improve muscle recovery after exercise/helps mantain optimal repair of muscle tissue/transports long-chain fatty acids into the mitocondria/plays an important role in lipid…” | Non-authorised | Art.13(1) | EFSA opinion |
| “Helps the energy production in the cell by transporting fatty acids in places where they are used and metabolised/contributes to the fat burning during exercise/contributes to increased fat oxidation/is important for the oxidation of fat/helps improve muscle recovery after exercise/helps mantain optimal repair of muscle tissue/transports long-chain fatty acids into the mitocondria/plays an important role in lipid…” | Non-authorised | Art.13(1) | EFSA opinion |
| “Helps to delay the onset of fatigue. Helps to maintain energy levels for prolonged periods during intense competition/exercise. Enhances endurance and helps to maintain peak effort during times of high physical demand.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Can increase L-Carnitine levels during pregnancy and lactation. Can help decrease free fatty acids during pregnancy. Can maintain normal L-Carnitine plasma levels during pregnancy.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Helps improve muscle recovery after exercise -helps maintain optimal repair of muscle tissue -supports athletes in recovery from weight training -can help recreationally weight-trained in recovery from exercise -contributes to the reduction of muscle soreness from exercise in trained athletes” | Non-authorised | Art.13(1) | EFSA opinion |
| “Improves sperm quality.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Makes energy metabolism more effective. Protects cell energy metabolism. Reduces changes in energy metabolism caused by ageing.” | Non-authorised | Art.13(1) | EFSA opinion |
| “L-carnitine and contribution to normal lipid metabolism” | Non-authorised | Art.13(5) | EFSA opinion |
Etalyn identifierETA-C-003411
Carnobacterium divergens EU-NOVEL Not yet graded
Not novel in food
also: Lactobacillus divergens
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-003412
Carnobacterium maltaromaticum EU-NOVEL Not yet graded
Not novel in food
also: Lactobacillus carnis; Lactobacillus piscicola; Carnobacterium piscicola
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-003413
Carnosine EU-CLAIMEU-NOVEL Not yet graded
Not novel in supplementsEU claims 0 authorised / 4 refused
Parts in scopeWhole
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Against skin ageing. Protects cells from ageing” | Non-authorised | Art.13(1) | EFSA opinion |
| “For a healthy heart” | Non-authorised | Art.13(1) | EFSA opinion |
| “Muscle power and endurance.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Muscle power and endurance.” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-003414